Nanoparticulate peptide delivery exclusively to the brain produces tolerance free analgesia. (2018)
Attributed to:
Technologies for the Treatment of Brain Diseases
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jconrel.2017.11.041
PubMed Identifier: 29191784
Publication URI: http://europepmc.org/abstract/MED/29191784
Type: Journal Article/Review
Volume: 270
Parent Publication: Journal of controlled release : official journal of the Controlled Release Society
ISSN: 0168-3659